Back to search
FDAFDA · Food and drugs·Recall number D-1090-2018

P/P/P (Prostaglandin/Papaverine/Phentolamine) Injection, 0.02/30/2 mg/mL, 5 mL vial, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.

Published August 22, 2018 · Recall initiated: July 25, 2018

Summary

FDA records drug Class II recall D-1090-2018, published August 22, 2018 and initiated July 25, 2018. Recalling firm: Ranier's Compounding Laboratory; Status: Terminated; Reported quantity: 2 vials; Lot: All lots within expiry. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Ranier's Compounding Laboratory
Distributor
Product was distributed within the state of Pennsylvania.
Lot
All lots within expiry
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was P/P/P (Prostaglandin/Papaverine/Phentolamine) Injection, 0.02/30/2 mg/mL, 5 mL vial, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644. recalled?

Yes. FDA published recall D-1090-2018 on August 22, 2018. Reported hazard: Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

What should I do if I have this product?

Voluntary: Firm initiated · Letter